Chronic Myelogenous Leukemia, BCR-ABL1 Positive

specific

A chronic myeloproliferative neoplasm characterized by the expression of the BCR-ABL1 fusion gene. It presents with neutrophilic leukocytosis. It can appear at any age, but it mostly affects middle aged and older individuals. Patients usually present with fatigue, weight loss, anemia, night sweats, and splenomegaly. If untreated, it follows a biphasic or triphasic natural course; an initial indolent chronic phase which is followed by an accelerated phase, a blast phase, or both. Allogeneic stem

21

Centers

1

Active Trials

Cancer Funding

Top Centers for Chronic Myelogenous Leukemia, BCR-ABL1 Positive(21)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
173.8
2
NCI Comprehensive
51.3
3
NCI Comprehensive
51.3
4
NCI Comprehensive
51.3
5
NCI Comprehensive
51.3
651.3
751.3
8
NCI Comprehensive
51.3
9
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
51.3
10
NCI Comprehensive
51.3
1151.3
12
NCI Comprehensive
51.3
13
NCI Comprehensive
51.3
1451.3
1551.3
1651.3
1751.3
18
NCI Comprehensive
51.3
1951.3
2051.3
2151.3

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →